SCHEMBL20323643

SCHEMBL20323643

CN1CCN(CC2CNC2)CC1

nearest known ligand 0.34

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ACHE P22303 2/20 0.34
HRH3 Q9Y5N1 3/20 0.33
NCF1 P14598 1/20 0.33
CHRM5 P08912 1/20 0.33
ADRA2C P18825 1/20 0.33
MC4R P32245 1/20 0.32
CACNA2D1 P54289 1/20 0.32
CACNA1B Q00975 1/20 0.32
CACNB1 Q02641 1/20 0.32
CACNA1C Q13936 1/20 0.32
HRH4 Q9H3N8 1/20 0.32
PAOX Q6QHF9 1/20 0.31
LMNA P02545 1/20 0.31
SIGMAR1 Q99720 1/20 0.30
HTR2A P28223 1/20 0.30
HTR2C P28335 1/20 0.30
HRH1 P35367 1/20 0.30
KCNH2 Q12809 1/20 0.30
ALDH1A1 P00352 1/20 0.30
TSHR P16473 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26706495 0.92 ACHE (0.41) ACHENCF1CHRM5ADRA2CCACNA2D1
SCHEMBL25571652 0.88 CHRM5 (0.40) ACHECHRM5ADRA2CKCNH2
SCHEMBL23484813 0.84 SLC6A1 (0.37) ACHEHRH3NCF1CHRM5ADRA2C
SCHEMBL2110725 0.84 SLC6A1 (0.37) ACHEHRH3NCF1CHRM5ADRA2C
SCHEMBL24480906 0.84 GNAI3 (0.44) ACHEHRH3NCF1CHRM5ADRA2C
SCHEMBL24833092 0.84 SLC6A1 (0.37) ACHEHRH3NCF1CHRM5ADRA2C
SCHEMBL25026748 0.82 TSHR (0.32) ALDH1A1TSHR
SCHEMBL13661309 0.81 CCR2 (0.43) ACHEHRH3CHRM5ADRA2CHRH4
SCHEMBL13213350 0.81 CCR2 (0.43) ACHEHRH3CHRM5ADRA2CHRH4
SCHEMBL27272511 0.81 CCR2 (0.43) ACHEHRH3CHRM5ADRA2CHRH4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3689868-B1 TETRAHYDRONAPHTHALENE AND TETRAHYDROISOQUINOLINE DERIVATIVES AS ESTROGEN RECEPTOR DEGRADERS ARVINAS OPERATIONS INC (US) 2023-09-27 EP disclosed
WO-2022047145-A1 RAPIDLY ACCELERATING FIBROSARCOMA PROTEIN DEGRADING COMPOUNDS AND ASSOCIATED METHODS OF USE ARVINAS OPERATIONS, INC. (US) 2022-03-03 WO disclosed
WO-2021194879-A1 INDAZOLE BASED COMPOUNDS AND ASSOCIATED METHODS OF USE ARVINAS OPERATIONS, INC. (US) 2021-09-30 WO disclosed
EP-3689868-A1 TETRAHYDRONAPHTHALENE AND TETRAHYDROISOQUINOLINE DERIVATIVES AS ESTROGEN RECEPTOR DEGRADERS Arvinas Operations, Inc. (US) 2020-08-05 EP disclosed
WO-2020081450-A1 BIFUNCTIONAL COMPOUNDS FOR DEGRADING BTK VIA UBIQUITIN PROTEOSOME PATHWAY NURIX THERAPEUTICS, INC. (US) 2020-04-23 WO disclosed
WO-2019199816-A1 CEREBLON LIGANDS AND BIFUNCTIONAL COMPOUNDS COMPRISING THE SAME ARVINAS OPERATIONS, INC. (US) 2019-10-17 WO disclosed
WO-2019195201-A1 BRM TARGETING COMPOUNDS AND ASSOCIATED METHODS OF USE ARVINAS OPERATIONS, INC. (US) 2019-10-10 WO disclosed
WO-2018119448-A1 COMPOUNDS AND METHODS FOR THE TARGETED DEGRADATION OF RAPIDLY ACCELERATED FIBROSARCOMA POLYPEPTIDES Arvinas, Inc. (US) 2018-06-28 WO disclosed